Literature DB >> 12707732

Osteopetrosis and Glanzmann's thrombasthenia in a child.

N Yarali1, T Fişgin, F Duru, A Kara.   

Abstract

Autosomal recessive osteopetrosis is a rare, fatal disease characterized by accumulation of excessive bone mass due to defective bone resorption. The pathogenesis of osteopetrosis is controversial. Osteoblast-osteoclast interaction defects, incorrect differentiation of osteoclasts, abnormal contact between osteoclast and extracellular matrix, and abolished signaling are included in this process. Recently, mutations in the gene of the vacuolar proton pump have been described in some cases of recessive osteopetrosis. Glanzmann's thrombasthenia (GT) is a rare hereditary qualitative platelet disorder characterized by a lifelong bleeding tendency due to quantitative and qualitative abnormalities of the platelet integrin alpha(IIb) beta3. Several mutations on either integrin alpha(IIb) [glycoprotein (GP) IIb] or integrin beta(3) (GP IIIa) were reported in GT. We report on a patient with autosomal recessive osteopetrosis concurrently diagnosed with variant type Glanzmann's thrombasthenia. To our knowledge, our patient was the first case reported in the literature in which osteopetrosis and Glanzmann's thrombasthenia were diagnosed together.

Entities:  

Mesh:

Year:  2003        PMID: 12707732     DOI: 10.1007/s00277-002-0571-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

Review 1.  Calcium and bone disease.

Authors:  Harry C Blair; Lisa J Robinson; Christopher L-H Huang; Li Sun; Peter A Friedman; Paul H Schlesinger; Mone Zaidi
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

Review 2.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

Review 3.  Osteoclast motility: putting the brakes on bone resorption.

Authors:  Deborah V Novack; Roberta Faccio
Journal:  Ageing Res Rev       Date:  2009-09-27       Impact factor: 10.895

Review 4.  Osteopetrosis: genetics, treatment and new insights into osteoclast function.

Authors:  Cristina Sobacchi; Ansgar Schulz; Fraser P Coxon; Anna Villa; Miep H Helfrich
Journal:  Nat Rev Endocrinol       Date:  2013-07-23       Impact factor: 43.330

5.  Kindlin-3 mutation in mesenchymal stem cells results in enhanced chondrogenesis.

Authors:  Bethany A Kerr; Lihong Shi; Alexander H Jinnah; Koran S Harris; Jeffrey S Willey; Donald P Lennon; Arnold I Caplan; Tatiana V Byzova
Journal:  Exp Cell Res       Date:  2021-01-05       Impact factor: 3.905

6.  'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass.

Authors:  C L Gregson; S A Steel; K P O'Rourke; K Allan; J Ayuk; A Bhalla; G Clunie; N Crabtree; I Fogelman; A Goodby; C M Langman; S Linton; E Marriott; E McCloskey; K E Moss; T Palferman; S Panthakalam; K E S Poole; M D Stone; J Turton; D Wallis; S Warburton; J Wass; E L Duncan; M A Brown; G Davey-Smith; J H Tobias
Journal:  Osteoporos Int       Date:  2011-04-01       Impact factor: 4.507

7.  Osteopetrosis with micro-lacunar resorption because of defective integrin organization.

Authors:  Harry C Blair; Beatrice B Yaroslavskiy; Lisa J Robinson; Markus Y Mapara; Alessandra Pangrazio; Lida Guo; Ka Chen; Paolo Vezzoni; Jakub Tolar; Paul J Orchard
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

Review 8.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.